XML 39 R31.htm IDEA: XBRL DOCUMENT v3.22.0.1
Liquidity (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jul. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Jun. 30, 2021
Cash   $ 9,900,000    
Total Current Liabilities   4,500,000    
Net loss   (3,900,000.0) $ (7,300,000)  
Working capital   5,500,000   $ 4,200,000
Future budget expenditures   8,300,000    
Clinical activities   6,300,000    
2020 Agreement [Member] | Aspire Capital [Member] | Class A Common Stock [Member]        
Aggregate purchase $ 30,000,000.0      
Common stock, shares issued 6,250,000      
Commitment fee $ 1,400,000      
Available balance   $ 25,400,000